BofA Reiterates Buy Rating on Ascendis Pharma (ASND) While Wells Fargo Analyst Raises PT

Ascendis Pharma A/S (NASDAQ:ASND) is one of the 11 Best Stocks to Buy for Investment. On January 27, BofA reiterated a Buy rating on Ascendis Pharma A/S (NASDAQ:ASND). Tazeen Ahmad at BofA retained the rating on ASND and maintained the price target at $246. BofA Reiterates Buy Rating on Ascendis Pharma, While Wells Fargo Analyst Upgrades PT on ASND adriaticfoto/Shutterstock.com In other news, on January 20, TheFly reported that Wells Fargo analyst Derek Archila upgraded the price target on Ascendis Pha ...